Navigation Links
Human Antibody Array I Kit, RayBio L Series 507: RayBio Label-based from Raybiotech, Inc.

ProductsHuman Antibody Array I Kit, RayBio L Series 507: RayBio Label-based from Raybiotech, Inc.
Company Raybiotech, Inc.
Item Human Antibody Array I Kit, RayBio L Series 507: RayBio Label-based
Price $680.00
Description RayBio L Series 507: RayBio Label-based Antibody Array I (1 glass slide with 2 subarrays)
Class: Antibody Array Products
Product Group: Antibody Array
Info Raybiotech, Inc.Raybiotech, Inc.
3607 Parkway Lane, Ste. 200
Norcross, GA 30092
Customer Service: (888) 494-8555
Fax Number: (770) 206-2393
Web Site: http://www.raybiotech.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Mouse Anti-Human S-100 alpha/beta chain Monoclonal Antibody, Unconjugated, Clone 8B10 from Santa Cruz Biotechnology, Inc.
2. Rabbit Anti-Human Vitamin K-dependent Protein S (PROS1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
3. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Placenta from OriGene Technologies
4. Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Heart from OriGene Technologies
5. Mouse Anti-Human Complement factor B Monoclonal Antibody, Unconjugated, Clone 9B6 from AntibodyShop A/S
6. Mouse Anti-Human Choriongonadotropin (hCG) Monoclonal Antibody, Unconjugated, Clone 5F10 from AntibodyShop A/S
7. Mouse Anti-Human Procollagen type I C-terminal propeptide (PICP) Monoclonal Antibody, Unconjugated from AntibodyShop A/S
8. Mouse Anti-Human Acetylcholinesterase, brain (AChE) Monoclonal Antibody, Unconjugated, Clone 12B4 from AntibodyShop A/S
9. Mouse Anti-Human a1-Antitrypsin (alpha-1 AT) Monoclonal Antibody, Unconjugated, Clone 4E5 from AntibodyShop A/S
10. pMIR-hU6-Luc, Human U6 Luciferase Control Vector from Mirus Bio Corporation
11. Human and Mouse RAR Neutralizing Peptide from ABR-Affinity BioReagents
Rabbit Anti-ICAD / DFF45 (NT) Polyclonal Antibody, Unconjugated from ProSci, Inc
Rabbit Anti-Human ZFP91 Polyclonal Antibody, Unconjugated from Abcam
Anti-AANAT Antibody, Unconjugated from CHEMICON
Rat Anti-B7 RP1 Monoclonal Antibody, Phycoerythrin Conjugated, Clone HK5.3 from Abcam
Biology Products:
(Date:11/9/2009)...mic, government and industry researchers has compl...ta) genome. The project is an important first step...istence crop and addressing some of the many limit... , Cassava is a root crop that serves as the pri...each day. Although it has many properties that mak...
(Date:11/9/2009)...Calif., Nov. 9 Genencor, a divisio...ergy Award" from the American Institute of Chemica...ly of enzymes for cellulosic ethanol. Yesterday, R...presented the award to Landon Steele, who is Marke...4; Product Manager, and Aaron Kelley, who is Senio...
(Date:11/9/2009)...lprit responsible for the rapid, mysterious death ...een found by collaborating scientists at Rutgers U...tion (WHOI). This same chemical may hold unexpect...ered a previously unknown lipid, or fatty compound...Emiliania huxleyi , a phytoplankton that plays a m...
Breaking Biology News(10 mins):Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Elbit Imaging Ltd Announces Sale of Plaza Centers Shares 5375 1Elbit Imaging Ltd Announces Sale of Plaza Centers Shares 5375 2Elbit Imaging Ltd Announces Sale of Plaza Centers Shares 5375 3Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR 28TM 29 Technology and Generate Novel Drug Leads Against a GPCR 14426 1Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR 28TM 29 Technology and Generate Novel Drug Leads Against a GPCR 14426 2Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR 28TM 29 Technology and Generate Novel Drug Leads Against a GPCR 14426 3Celsense Inc Files FDA 26amp 3B EMEA Regulatory Submissions 59274 1Celsense Inc Files FDA 26amp 3B EMEA Regulatory Submissions 59274 2Celsense Inc Files FDA 26amp 3B EMEA Regulatory Submissions 59274 3
...Cellulose--a fibrous molecule found in all plants-.... It is also a favored target of renewable, plant-...rest, scientists know relatively little about how .... , However, recent work from the Carnegie Institu...iversity describes the first real-time observation...
...Researchers at Dana-Farber Cancer Institute have i...particularly aggressive form of breast cancer, and... drugs might improve treatment. , In the January ... and Peter Sicinski, MD, PhD, of Dana-Farber repor...ne and the newly described growth control flaw is ...
...A group of scientists from Oregon have discovered ...at during metamorphosis. The details of their fin...Lipid Research, an American Society for Biochemist...ation of a caterpillar to a butterfly is one on na... the Oregon Health and Science University in Portl...
Other Biology News:Formation of cellulose fibers tracked for the first time 2New cellular flaw found in some virulent breast cancers 2New cellular flaw found in some virulent breast cancers 3Butterflies lose body fat during metamorphosis 2
(Date:11/9/2009)... November 9 Following the provisio...nd Drug Administration (FDA), privately,owned UK c...valinternational.com ) has been informed that its ...been awarded an Orphan-Drug,designation for the tr..., ALS, also known as Lou Gehrig,s disease, ...
(Date:11/8/2009)... VIEW, Calif. Nov. 5, 2009 Complete Genomics, a ...today announced publication of a report in the jou...encing platform, including analysis of sequence da...les cost for these three genomes sequenced on the ...rom $8,005 for 87x coverage to $1,726 for 45x cove...
(Date:11/6/2009)...v. 6 /PRNewswire-FirstCall/ - Microbix Biosystems ...e-filed the Form 52-109F1 Certification of Annual ...icer and James Long, the Chief Financial Officer (...09 in connection with the annual audited financial... ,, The Company initially filed the annual fina...
(Date:11/6/2009)...ario, Nov. 6 Helix BioPh...today announced that John Docherty, president and ...Curhan Ford,s 6th annual Investor Summit on Novemb... York City. Mr. Docherty will provide an overview...rams L-DOS47 and Topical Interferon Alpha-2b. The...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3